Congratulations to the Centre’s 2022 Honours students on their scholarship awards and we wish them all the best for their research and training
Validation of the Male Depression Risk Scale short form in a cross-sectional study of Australian men. Herreen D, Rice S, Zajac I. Brief assessment of male depression in clinical care:BMJ Open. 2022 Mar 28;12(3):e053650. doi: 10.1136/bmjopen-2021-053650.
Contact: Dr Ian Zajac
To celebrate International Women’s Day, the Centre is highlighting some of the fantastic women of men’s health that have been supported by the Centre and are achieving great work in the field. FCMHW encourages and commends the involvement of women in men’s health and hopes to further support it in the future.
Optical Cellular Micromotion: A new paradigm to measure tumor cells Invasion within gels mimicking the 3D tumor environments.
Guo Z, Yang CT, Chien CC, Selth LA, Bagnaninchi PO, Thierry B. Small Methods. 2022 Jun 28:e2200471. doi: 10.1002/smtd.202200471.
Contact: Luke Selth
Effects of androgens on glucose metabolism. Umapathysivam M, Grossmann M, Wittert GA. Best Pract Res Clin Endocrinol Metab. 2022 Mar 31:101654. doi: 10.1016/j.beem.2022.101654.
Contact: Gary Wittert
Level playing field: young males, masculinity and mental wellbeing through sport.
Drummond, M., Wadham, B., Prichard, I. et al. BMC Public Health 22, 756 (2022). https://doi.org/10.1186/s12889-022-13200-1.
Contact: Murray Drummond
Validation of the Male Depression Risk Scale short form in a cross-sectional study of Australian men. Herreen D, Rice S, Zajac I. Brief assessment of male depression in clinical care:BMJ Open. 2022 Mar 28;12(3):e053650. doi: 10.1136/bmjopen-2021-053650.
Contact: Dr Ian Zajac
Unravelling Prostate Cancer Heterogeneity Using Spatial Approaches to Lipidomics and Transcriptomics. Cancers. Mutuku SM, Spotbeen X, Trim PJ, Snel MF, Butler LM, Swinnen JV. (Basel). 2022 Mar 27;14(7):1702. doi: 10.3390/cancers14071702.
Contact: Lisa Butler
Harnessing the Heterogeneity of Prostate Cancer for Target Discovery Using Patient-Derived Explants. Centenera MM, Vincent AD, Moldovan M, Lin HM, Lynn DJ, Horvath LG, Butler LM. Cancers (Basel). 2022 Mar 28;14(7):1708. doi: 10.3390/cancers14071708.
Contact: Lisa Butler
Understandings and experiences of adherence to secondary prevention for patients with cardiovascular disease and comorbid depression or anxiety. Cosh SM, Pinto R, Denson L, Tully PJ Psychol Health Med. 2022 Mar 31:1-8. doi: 10.1080/13548506.2022.2060515. Epub ahead of print. PMID: 35356823.
Contact: Phillip Tully
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer. Mak B, Lin HM, Kwan EM, Fettke H, Tran B, Davis ID, Mahon K, Stockler MR, Briscoe K, Marx G, Zhang A, Crumbaker M, Tan W, Huynh K, Meikle TG, Mellett NA, Hoy AJ, Du P, Yu J, Jia S, Joshua AM, Waugh DJ, Butler LM, Kohli M, Meikle PJ, Azad AA, Horvath LG. BMC Med. 2022 Mar 25;20(1):112. doi: 10.1186/s12916-022-02298-0.
Contact: Lisa Butler
David R, Buckby A, Kahokehr AA, Lee J, Watson DI, Leung J, O'Callaghan ME. Prostate Cancer Prostatic Dis. 2022 Mar 8. doi: 10.1038/s41391-022-00520-x.
Contact: Michael O’Callaghan
A novel EEG marker predicts perceived SLEEPINESS AND poor sleep quality. Lechat B, Hirotsu C, Appleton S, Younes M, Adams RJ, Vakulin A, Hansen K, Zajamsek B, Wittert G, Catcheside P, Heinzer R, Eckert DJ. Sleep. 2022 Mar 4:zsac051. doi: 10.1093/sleep/zsac051.
Contact:Robert Adams
This research aims to translate the Centre’s research into an impactful health service integration program targeting the patient-GP interface, arming men with the knowledge, motivation, and agency to recognize symptoms and health behaviours as prompts to engage with primary health care services, and providing men and GPs with tools that optimise the outcomes of that engagement.
Contact: Professor Gary Wittert
We will partner with researchers and community outreach officers at Cancer Council SA (lead by Dr Jess Loyer), the Multicultural Communities of South Australia Men’s Group who are investigating barriers to engagement with cancer control programs among CALD communities.
This program aims to adapt the current RACGP prostate cancer screening decision-making tool to be culturally sensitive and meet the needs of men from CALD backgrounds and improve the uptake of PSA screening which will facilitate early detection and treatment/monitoring of prostate cancer.
Contact: Dr Norma Bulamu
